Relative Bioavailability of intact and sprinkled 20 mg Lomitapide

• Research type

  Research Study

• Full title

  A Phase 1, Open-label, Randomised, Crossover Study to determine the Comparative Bioavailability of 20 mg Lomitapide Where the Contents Have Been Opened and Sprinkled in Applesauce or Mashed Banana (“Sprinkled Contents”) to a Single Oral Capsule Dose of 20 mg Lomitapide (“Intact Capsule”) in Healthy Subjects

• IRAS ID

  137629

• Contact name

  Ulrike Lorch

• Contact email

  u.lorch@richmondpharmacology.com

• Sponsor organisation

  Aegerion Pharmaceuticals, Inc.

• Eudract number

  2013-003677-10

• ISRCTN Number

  N/A

• Clinicaltrials.gov Identifier

  N/A

• REC name

  South Central - Berkshire B Research Ethics Committee

• REC reference

  13/SC/0487

• Date of REC Opinion

  22 Oct 2013

• REC opinion

  Further Information Favourable Opinion